Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.

Bibliographic Details
Main Authors:	Hasle, H, Abrahamsson, J, Arola, M, Karow, A, O'Marcaigh, A, Reinhardt, D, Webb, D, van Wering, E, Zeller, B, Zwaan, C, Vyas, P
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Akin Afar
by: Lau, Yi Wen
Published: (2019)

Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
by: Islam, M., et al.
Published: (2017)

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.
by: Grimwade, D, et al.
Published: (1999)

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
by: Grimwade, D, et al.
Published: (1996)

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials.
by: Peniket, A, et al.
Published: (1999)

Cytogenetic profiles and their clinical significance in relapsed multiple myeloma
by: Lin, Qian Yu
Published: (2023)

Natural history of GATA-1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2003)

Cytogenetic profile of acute myeloid leukaemia (AML) patients in Singapore General Hospital (SGH)
by: Ho, Charmaine Jia Yi
Published: (2024)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
by: Fernandez-Mercado, M, et al.
Published: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
by: Fernandez-Mercado, M, et al.
Published: (2013)

Natural history of GATA1 mutations in Down syndrome.
by: Ahmed, M, et al.
Published: (2004)

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics
by: Fernandez-Mercado, M, et al.
Published: (2012)

Characterization of additional cytogenetic abnormalities in haematological patients upon disease relapse.
by: Chee, Joyce Yuen Yin.
Published: (2012)

Expert: Elimination of GST akin to supporting tax cheating
by: News Straits, Times
Published: (2017)

Agency in contemporary German cinema: Tykwer, Akın and Petzold
by: Burt, S
Published: (2017)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
by: Roberts, I, et al.
Published: (2013)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
by: Alford, K, et al.
Published: (2011)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
by: Grimwade, D, et al.
Published: (1998)

Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: results from the NCRI AML trials
by: Hills, R, et al.
Published: (2018)

TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis
by: Moorman, A, et al.
Published: (2005)

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
by: Grimwade, D, et al.
Published: (2001)

Outcome of critically ill patients with acute kidney injury using the akin criteria
by: Mandelbaum, Tal, et al.
Published: (2012)

Lack of knowledge among workers often leads to chemical exposure
by: Ng, Yee Guan
Published: (2021)

Flow cytogenetics/
by: Gray, Joe W.
Published: (1989)

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.
by: Kottaridis, P, et al.
Published: (2000)

Stage IV adult sporadic Burkitt lymphoma/leukemia with complex bone marrow cytogenetics is associated with a very poor outcome.
by: Tholouli, E, et al.
Published: (2009)

Assert Early‚ Assert Often
by: Hoare, C
Published: (2002)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
by: Hellebostad, M, et al.
Published: (2005)

Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML
by: Risueño, A, et al.
Published: (2024)

Review of: Akins, Faren R. et al.: Behavioral Development in Nonhuman Primates: An Abstracted Bibliography
by: Reynolds, V
Published: (1980)

Cytogenetics in the 1970s and 1980s.
by: Wolstenholme, J, et al.
Published: (2010)

Study: Transparency is Often Lacking in Datasets Used to Train Large Language Models
by: Zewe, Adam
Published: (2024)

AML-399 A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acute myeloid leukemia (AML)
by: Vyas, P, et al.
Published: (2022)

Gene expression profiling in MDS and AML: potential and future avenues.
by: Theilgaard-Mönch, K, et al.
Published: (2011)

Nematode isoenzyme studies and cytogenetics
by: Yong, Hoi Sen, et al.
Published: (1988)

Nematode isoenzyme studies and cytogenetics
by: Yong, Hoi Sen, et al.
Published: (1988)

Koller and the dawn of cancer cytogenetics
by: Norbury, CJ
Published: (2022)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
by: Norton, A, et al.
Published: (2007)